Structure-Based Design and Synthesis of a Potent Matrix Metalloproteinase-13 Inhibitor Based on a Pyrrolidinone Scaffold-Reference-Cited by-同舟云学术

Structure-Based Design and Synthesis of a Potent Matrix Metalloproteinase-13 Inhibitor Based on a Pyrrolidinone Scaffold

Published:2000-05-27 Issue:12 Volume:43 Page:2293-2296
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Robinson Ralph P.¹,Laird Ellen R.¹,Blake James F.¹,Bordner Jon¹,Donahue Kathleen M.¹,Lopresti-Morrow Lori L.¹,Mitchell Peter G.¹,Reese Matthew R.¹,Reeves Lisa M.¹,Stam Ethan J.¹,Yocum Sue A.¹

Affiliation:

1. Central Research Division, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0001368

Reference25 articles.

1. Matrix metalloproteinase inhibitors 1998

2. New Drugs on the Horizon: Matrix Metalloproteinase Inhibitors

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereoselective synthesis of trifluoroethyl 3,2′-spirooxindole γ-lactam through the organocatalytic cascade reaction of 3-((2,2,2-trifluoroethyl)amino)indolin-2-one;Organic & Biomolecular Chemistry;2021

2. Efficient synthesis of tert-butyl 3-cyano-3-cyclopropyl-2-oxopyrrolidine-4-carboxylates: Highly functionalized 2-pyrrolidinone enabling access to novel macrocyclic Tyk2 inhibitors;Bioorganic & Medicinal Chemistry Letters;2020-03

3. Reactions of 3-pyrrolin-2-ones;Advances in Heterocyclic Chemistry;2019

4. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays;Bioorganic & Medicinal Chemistry;2016-09

5. Biologically active γ-lactams: synthesis and natural sources;Organic & Biomolecular Chemistry;2016